Senior author and NYU Assistant Professor Dr Karan Chhabra on larger studies to address drug efficacy and who could do better ...

INDIANAPOLIS — Eli Lilly filed lawsuits against compounding pharmacies and an Indianapolis weight loss company over the use of Zepbound and Mounjaro. On April 1, 2025, Lilly filed lawsuits against two ...

A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

Demand for Mounjaro cannot realistically be metType 2 diabetes medication Mounjaro is less than a week away from being ...

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and Orlistat.

Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

General practitioners across the NHS are urging patients to cease requests for weight loss injections as they prepare for the ...

There’s a lot of stigma around Mounjaro and a recent study found that people think weight loss that’s brought on by weight ...

Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.